Kaisa Hanley

Title(s)Postdoctoral Scholar, Pathology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Deciphering cross-talk of signaling pathways in control of hepatocellular carcinogenesis
    NIH F31CA228420Dec 7, 2018 - Dec 6, 2020
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The most impactful findings on liver cancer in 2023. Hepatol Commun. 2024 Apr 01; 8(4). Lee J, Hanley KL, Feng GS. PMID: 38466874; PMCID: PMC10932523.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Concurrent Disruption of the Ras/MAPK and NF-κB Pathways Induces Circadian Deregulation and Hepatocarcinogenesis. Mol Cancer Res. 2022 Mar 01; 20(3):337-349. Hanley KL, Liang Y, Wang G, Lin X, Yang M, Karin M, Fu W, Feng GS. PMID: 34810213; PMCID: PMC8898265.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    3. Single-cell transcriptomics reveals opposing roles of Shp2 in Myc-driven liver tumor cells and microenvironment. Cell Rep. 2021 11 09; 37(6):109974. Chen WS, Liang Y, Zong M, Liu JJ, Kaneko K, Hanley KL, Zhang K, Feng GS. PMID: 34758313; PMCID: PMC8656042.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    4. Androgen receptor, neovascularization and liver cancer metastasis. J Hepatol. 2021 10; 75(4):768-769. Feng MW, Hanley KL, Feng GS. PMID: 34233845; PMCID: PMC9948677.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    5. Improving the Efficacy of Liver Cancer Immunotherapy: The Power of Combined Preclinical and Clinical Studies. Hepatology. 2021 01; 73 Suppl 1:104-114. Feng GS, Hanley KL, Liang Y, Lin X. PMID: 32715491; PMCID: PMC7854886.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimals
    6. Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating Cells. Cell Rep. 2016 12 13; 17(11):2979-2993. Luo X, Liao R, Hanley KL, Zhu HH, Malo KN, Hernandez C, Wei X, Varki NM, Alderson N, Chu C, Li S, Fan J, Loomba R, Qiu SJ, Feng GS. PMID: 27974211; PMCID: PMC5330282.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    7. A new VETC in hepatocellular carcinoma metastasis. Hepatology. 2015 Aug; 62(2):343-5. Hanley KL, Feng GS. PMID: 25902918; PMCID: PMC5330284.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells